Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2019-03-28 2019-03-28
Drug Identification Number 02425718 02425718
Brand name CISATRACURIUM BESYLATE INJECTION CISATRACURIUM BESYLATE INJECTION
Common or Proper name Cisatracurium Besylate Injection Cisatracurium Besylate Injection
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CISATRACURIUM CISATRACURIUM
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 10mL 10 x 10mL
ATC code M03AC M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-03-25 2019-03-25
Remaining supply date 2019-03-25 2019-03-25
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments